About This Book
"Drug Abuse Data" presents a data-driven examination of global drug misuse, offering readers a comprehensive analysis of its societal impact, from economic burdens to public health challenges. Through statistical evidence and research findings, this book illuminates the complex interplay between substance abuse, healthcare systems, and policy responses worldwide. The book addresses three core areas: the measurable economic costs of drug abuse across different societies, the quantifiable health impacts on populations, and the evidence-based evaluation of various policy approaches. These interconnected themes provide a foundation for understanding both the scope of drug misuse and potential solutions. Drawing from epidemiological studies, healthcare data, and economic analyses spanning the past three decades, the text establishes crucial context for current drug abuse patterns. Readers will gain insight into how demographic shifts, policy changes, and social factors have influenced substance use trends across different regions and populations. The central thesis argues that effective drug policy must be based on verifiable data rather than ideological positions, demonstrating how evidence-based approaches lead to more successful outcomes in both treatment and prevention. This position is supported by extensive research from public health institutions, law enforcement agencies, and academic studies. The book's structure progresses from defining the scope of global drug abuse through statistical analysis, examining economic impacts using cost-benefit studies, and culminating in an assessment of various policy approaches. Each chapter builds upon established research while incorporating recent findings from international health organizations and government agencies. Methodologically, the work combines epidemiological data, economic modeling, and public health statistics to create a comprehensive picture of drug abuse impacts. It features original analysis of datasets from the World Health Organization, United Nations Office on Drugs and Crime, and national health services. The interdisciplinary approach bridges public health, economics, and social policy, while incorporating relevant insights from behavioral psychology and criminal justice. This integration provides readers with multiple perspectives on drug abuse challenges and potential solutions. Written in an academic yet accessible style, the book presents complex data through clear visualizations, tables, and case studies. The content maintains scientific rigor while ensuring key concepts are understandable to readers with basic health literacy. The target audience includes healthcare professionals, policy makers, researchers, and students in public health and social sciences. The book serves as both a comprehensive reference and an analytical tool for understanding drug abuse trends and interventions. Each chapter includes practical applications, enabling readers to apply findings to their professional contexts, whether in healthcare administration, policy development, or community health programs. The text addresses ongoing debates in drug policy, including harm reduction versus abstinence-based approaches, the role of criminal justice in addressing substance abuse, and the effectiveness of various treatment modalities. These discussions are grounded in statistical evidence rather than ideological positions. The book's scope encompasses both illicit substances and prescription drug abuse, though it focuses primarily on substances with the highest documented public health impact. Geographic coverage is global, with detailed analysis of patterns in both developed and developing nations. This resource fills a critical gap in the literature by providing current, comprehensive data on drug abuse trends and impacts, making it valuable for evidence-based decision making in public health and policy spheres. It distinguishes itself through its emphasis on quantifiable impacts and evidence-based solutions, offering a clear-eyed view of one of society's most persistent challenges.
"Drug Abuse Data" presents a data-driven examination of global drug misuse, offering readers a comprehensive analysis of its societal impact, from economic burdens to public health challenges. Through statistical evidence and research findings, this book illuminates the complex interplay between substance abuse, healthcare systems, and policy responses worldwide. The book addresses three core areas: the measurable economic costs of drug abuse across different societies, the quantifiable health impacts on populations, and the evidence-based evaluation of various policy approaches. These interconnected themes provide a foundation for understanding both the scope of drug misuse and potential solutions. Drawing from epidemiological studies, healthcare data, and economic analyses spanning the past three decades, the text establishes crucial context for current drug abuse patterns. Readers will gain insight into how demographic shifts, policy changes, and social factors have influenced substance use trends across different regions and populations. The central thesis argues that effective drug policy must be based on verifiable data rather than ideological positions, demonstrating how evidence-based approaches lead to more successful outcomes in both treatment and prevention. This position is supported by extensive research from public health institutions, law enforcement agencies, and academic studies. The book's structure progresses from defining the scope of global drug abuse through statistical analysis, examining economic impacts using cost-benefit studies, and culminating in an assessment of various policy approaches. Each chapter builds upon established research while incorporating recent findings from international health organizations and government agencies. Methodologically, the work combines epidemiological data, economic modeling, and public health statistics to create a comprehensive picture of drug abuse impacts. It features original analysis of datasets from the World Health Organization, United Nations Office on Drugs and Crime, and national health services. The interdisciplinary approach bridges public health, economics, and social policy, while incorporating relevant insights from behavioral psychology and criminal justice. This integration provides readers with multiple perspectives on drug abuse challenges and potential solutions. Written in an academic yet accessible style, the book presents complex data through clear visualizations, tables, and case studies. The content maintains scientific rigor while ensuring key concepts are understandable to readers with basic health literacy. The target audience includes healthcare professionals, policy makers, researchers, and students in public health and social sciences. The book serves as both a comprehensive reference and an analytical tool for understanding drug abuse trends and interventions. Each chapter includes practical applications, enabling readers to apply findings to their professional contexts, whether in healthcare administration, policy development, or community health programs. The text addresses ongoing debates in drug policy, including harm reduction versus abstinence-based approaches, the role of criminal justice in addressing substance abuse, and the effectiveness of various treatment modalities. These discussions are grounded in statistical evidence rather than ideological positions. The book's scope encompasses both illicit substances and prescription drug abuse, though it focuses primarily on substances with the highest documented public health impact. Geographic coverage is global, with detailed analysis of patterns in both developed and developing nations. This resource fills a critical gap in the literature by providing current, comprehensive data on drug abuse trends and impacts, making it valuable for evidence-based decision making in public health and policy spheres. It distinguishes itself through its emphasis on quantifiable impacts and evidence-based solutions, offering a clear-eyed view of one of society's most persistent challenges.
"Drug Abuse Data" delivers a comprehensive, data-driven exploration of global substance abuse, examining its profound impact on society through the lens of public health, economics, and policy effectiveness. The book uniquely combines decades of epidemiological studies, healthcare statistics, and economic analyses to present a clear picture of drug abuse patterns and their consequences worldwide. Through careful analysis of data from prestigious organizations like the World Health Organization and the United Nations Office on Drugs and Crime, it establishes a solid foundation for understanding current trends and potential solutions. The text progresses logically from defining the global scope of drug abuse to examining specific economic impacts and policy outcomes. It tackles three fundamental areas: economic costs across different societies, quantifiable health impacts on populations, and evidence-based evaluation of policy approaches. What sets this book apart is its steadfast commitment to verifiable data over ideological positions, making it an invaluable resource for healthcare professionals, policymakers, and researchers seeking concrete evidence for decision-making. The book bridges multiple disciplines while maintaining accessibility, using clear visualizations and case studies to illuminate complex concepts. It covers both illicit substances and prescription drug abuse, offering comparative analyses between developed and developing nations. By incorporating practical applications in each chapter and grounding discussions in statistical evidence, the text provides readers with actionable insights for addressing drug abuse challenges in various professional contexts, from healthcare administration to community health programs.
Book Details
ISBN
9788233940522
Publisher
Publifye AS
Your Licenses
You don't own any licenses for this book
Purchase a license below to unlock this book and download the EPUB.
Purchase License
Select a tier to unlock this book
Need bulk licensing?
Contact us for enterprise agreements.